GlaxoSmithKline Recalling Ventolin Inhalers for Possible Package Leakage
GlaxoSmithKline (GSK) issued a voluntary Class II recall on April 4, 2017 for three lots of Ventolin® HFA 200D Inhalers from U.S. hospitals, pharmacies, retailers and wholesalers as a precautionary measure. It is not a consumer recall. The lot numbers
